High-tech gene-therapy advances offer hope for patients with hard-to-treat blood disorders

A series of advancements in genetically engineered cell therapies demonstrate early efficacy and safety in patients with blood disorders for whom standard treatments have been unsuccessful, according to data showcased today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/aso…


Hacer un comentario